Nanjing Well Pharmaceutical Group Co.,Ltd. (603351.SS) SHH

Currency In CNY

AD

Valuation

Market Cap3.54B
Enterprise Value3.66B
P/E Ratio23.64
PEG Ratio8.59
Price/Sales Ratio2.67
Price/Book Ratio1.94
Enterprise/Revenue2.77
Enterprise/EBITDA12.76

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.11
Operating Margin0.13
AD

Management Effectiveness

Return On Assets0.06
Return On Equity0.09

Income Statement

Revenue1.34B
Revenue/Share9.98
Gross Profit380M
EBITDA316.04M
Net Income150.97M
Diluted EPS1.11

Balance Sheet

Total Cash438.46M
Total Cash/Share3.26
Total Debt563.02M
Total Debt/Equity0.31
Current Ratio1.39
Book Value Per Share13.7

Price History

52-Week Change1.96
52-Week High33.34
52-Week Low23.24
Moving Average 50 Days26.26
Moving Average 200 Days26.91

Statistics

Average Volume1.11M
Shares Outstanding135.44M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.6
Trailing Annual Dividend Yield2.27
Payout Ratio0.42
Last Split Factor7:5
Last Split DateMay 27, 2020
AD